Tate & Lyle PLC INTERIM MANAGEMENT STATEMENT - Jul 2014

| Filed in:

24 July 2014 – Tate & Lyle PLC

INTERIM MANAGEMENT STATEMENT

This Interim Management Statement covers the period from 1 April 2014 to 30 June 2014, which is the first quarter of the financial year.

OPERATING PERFORMANCE

The Group had a challenging first quarter as we dealt with the anticipated impact of the prolonged and severe winter in the US and also an unexpected shut down of our SPLENDA Sucralose facility in Singapore. These factors, together with the adverse impact of the strength of sterling against the US dollar and other currencies, meant that Group adjusted operating profit for the first quarter was below our expectations. However, overall customer demand remains strong and we continue to expect that the Group’s results in constant currency for the financial year will be broadly in line with our expectations when we announced our full-year results in May 2014.

As previously indicated, the first quarter started slowly in the US following the prolonged and severe winter which caused operational difficulties at the corn plants and led us to enter the current financial year with much lower inventories than usual. Although the impact on Bulk Ingredients was less than originally anticipated, it was greater on Speciality Food Ingredients, as we had to balance production to best meet our customers’ needs. Inventories continue to re-build and are expected to return to more normal levels in the current quarter.

In Speciality Food Ingredients, we once again delivered good volume growth in the emerging markets although overall growth was held back by the US where, despite firm demand, volumes were only marginally ahead of the comparable period as a result of the supply constraints. The £100 million investment programme announced in May will provide greater flexibility to mitigate this kind of issue in the future.

Volumes for SPLENDASucralose in the quarter were slightly lower than we expected predominantly due to a change in a large customer’s order pattern. Overall, the sucralose market continues to be competitive and dynamic with the pressure on pricing in line with our expectations.

Following an industrial accident, production at our Singapore facility was temporarily suspended while the local authorities conducted their investigations and remained shut down for a longer period than we originally anticipated. We incurred £3 million of costs to resolve issues caused by this unexpected stoppage. During the quarter there was limited production and customer orders were largely met from inventories. As a result, fixed manufacturing costs of £8 million were expensed and reduced profits for the quarter, but these will reverse in the second half of the year. We also brought forward and will extend the running time at our McIntosh facility in the US although this had limited impact in the quarter due to the normal lead times. Both plants are now running with Singapore returning to normal production levels.

As expected, sales in Bulk Ingredients in North America were constrained by entering the financial year with much lower inventories in the US than usual following the prolonged and severe winter. This impacted most product lines, although it was less than originally anticipated, and was also partially mitigated by firmer ethanol margins.

DEBT MANAGEMENT AND BALANCE SHEET

The Group’s financial position strengthened during the period. Net debt of £271 million at 30 June 2014 has reduced from £353 million at 31 March 2014, aided by the translation effects of a stronger sterling.

Following the quarter end, we renewed the Group’s US$800 million committed revolving credit facility for a further period of five years.

OUTLOOK

Overall, the Group’s full year performance, before the impact of exchange rate movements, is expected to be broadly in line with our previous guidance.

Performance in the first half will be impacted by the supply constraints in the first quarter and the temporary Singapore shut down, while the second half will benefit from the reversal of the Singapore costs. Accordingly, Group profits are expected to be weighted to the second half of the financial year.

The underlying divisional mix of profits in the first quarter is expected to be reflected in the full year and consequently we now expect the performance of Speciality Food Ingredients for the full year to be slightly lower than we anticipated. However, demand continues to be strong and, notwithstanding current market conditions for sucralose, for the full year Speciality Food Ingredients is expected to deliver volume growth above the wider speciality food ingredients market.


END

A conference call will be held today at 7:30am BST, hosted by Javed Ahmed, Chief Executive and Tim Lodge, Chief Financial Officer. Participants are requested to dial in at least 10 minutes before the commencement of the call. Dial in details are as follows:

Standard International Access: +44 (0) 20 3003 2666
Password: Tate & Lyle

UK replay number: +44 (0)20 8196 1998

International replay numbers: http://www.meetingzone.com/en-GB/replaydialinnumbers.aspx
Replay access PIN: 4120434

A replay of this call will be available after the end of the live call for 14 days until 7 August 2014.

SPLENDA is a trademark of McNeil Nutritionals, LLC.

Before exceptional items and amortisation of acquired intangible assets.

The translation of prior period results using actual rates for the quarter to date and rates as at 30 June 2014 (US/ £1.71 and Euro/ £1.25) for the balance of the financial year has the effect of reducing adjusted operating profit for the first half of the year by £17 million and the full year by £24 million.


Contact information
Christopher Marsh
Group VP, Investor and Media Relations
Tate & Lyle PLC
+44 (0)207 257 2110
+44 (0)779 619 2688
[email protected]

Andrew Lorenz
FTI Consulting
+44 (0) 20 7269 7113
+44 (0) 7775 641 807
[email protected]

Click here for our press image gallery

About Tate & Lyle: 
Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, fortification, and texture, we develop ingredient solutions which reduce sugar, calories, and fat, add fibre and protein, and provide texture and stability in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.

We have more than 3,500 employees working in around 57 locations across 39 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives Through the Science of Food. By living our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2023, Tate & Lyle revenue from continuing operations totalled £1.75 billion. For more information, please visit https://www.tateandlyle.com or follow Tate & Lyle on LinkedinX (Twitter)Facebook or YouTube